Top View
- Effects of Magnolol on UVB-Induced Skin Cancer Development in Mice and Its Possible Mechanism of Action Chandeshwari Chilampall South Dakota State University
- 137 Role of Natural Compounds in Preventing and Treating Breast
- Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment
- STAT3 and Its Inhibitors: Curcumin, Parthenolide, Resveratrol, Epigallocatechin-3-Gallate, Silibinin and Ursolic Acid
- Lignans and Their Derivatives from Plants As Antivirals
- WO 2016/124754 Al 11 August 2016 (11.08.2016) P O P C T
- Pilot Study of Oral Silibinin, a Putative Chemopreventive Agent, in Colorectal Cancer Patients
- Chemopreventive Effects of Honokiol on UVB-Induced Skin Cancer Development
- A New Class of Synthetic Flavonolignan-Like Dimers: Still Few Molecules, but with Attractive Properties
- Cell Systems to Investigate the Impact of Polyphenols on Cardiovascular Health
- Silibinin Up-Regulates Insulin-Like Growth Factor-Binding Protein 3 Expression and Inhibits Proliferation of Androgen-Independent Prostate Cancer Cells1
- Silymarin and Cancer: a Dual Strategy in Both in Chemoprevention and Chemosensitivity
- 04 DDT-12-00032-OA Proof Pp140-146.Indd
- Plant Phenolics and Extracts in Animal Models of Preeclampsia and Clinical Trials—Review of Perspectives for Novel Therapies
- Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy
- Molecular Insight Into Isoform Specific Inhibition of PI3K-Α and PKC-Η With
- Inhibitory Effect of Carnosol on Phthalic Anhydride-Induced Atopic Dermatitis Via Inhibition of STAT3
- Autophagy Modulation and Cancer Prevention
- Arzneimittelliste Nach ATC-Code Kantonsspital Baden AG
- (12) United States Patent (10) Patent No.: US 8,551,507 B2 Liu (45) Date of Patent: Oct
- Screening Naturally Occurring Phenolic Antioxidants for Their Suitability As Additives to CHO Cell Culture Media Used to Produce Monoclonal Antibodies
- Silibinin: an Inhibitor of Mir-181A Gene Expression in Sk-Br-3 Breast Cancer Cell Line
- Silibinin Strongly Synergizes Human Prostate Carcinoma DU145 Cells to Doxorubicin-Induced Growth Inhibition, G 2-M Arrest, and Apoptosis
- Silibinin a Decreases Statin‑Induced PCSK9 Expression in Human Hepatoblastoma Hepg2 Cells
- Silybum Marianum in Vitro-Flavonolignan Production
- Effects of Polyphenols on Oxidative Stress-Mediated Injury in Cardiomyocytes
- Honokiol Causes G0-G1 Phase Cell Cycle Arrest in Human Prostate
- Silibinin Inhibits Adipogenesis and Induces Apoptosis in 3T3-L1 Adipocytes
- Silibinin Suppresses Mediators of Inflammation Through the Inhibition of TLR4-TAK1 Pathway in LPS-Induced RAW264.7 Cells
- Inhibitory Effects of Magnolol and Honokiol on Human Calcitonin Aggregation
- The Molecular Basis of Working Mechanism of Natural Polyphenolic Antioxidants ⇑ Monica Leopoldini, Nino Russo , Marirosa Toscano
- Flaxseed Lignans As Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets
- Guidelines for ATC Classification and DDD Assignment 2021
- SUPPLEMENTARY MATERIAL Atractylenolide I Enhances
- Suppression of Gastric Cancer by Extract from the Tuber of Amorphophallus Konjac Via Induction of Apoptosis and Autophagy
- Guidelines for ATC Classification and DDD Assignment 2011
- Polyphenol-Mediated Autophagy in Cancer: Evidence of in Vitro and in Vivo Studies
- The Inhibition of Activated Hepatic Stellate Cells Proliferation By
- The Plants of the Asteraceae Family As Agents in the Protection of Human Health
- Cellular and Molecular Targets of Silibinin, a Natural Flavonoid, in Colorectal Cancer Prevention and Therapy Henriette Kauntz
- Honokiol Suppresses Metastasis of Renal Cell Carcinoma by Targeting KISS1/KISS1R Signaling
- Chemopreventive Compounds from Plant Derived Food and Their Bioactivity
- Evaluation of the Status Quo of Polyphenols Analysis: Part I—Phytochemistry, Bioactivity, Interactions, and Industrial Uses
- NIH Medical Research Program Directed Against Chemical Threats 2017 Report on Research Progress and Future Directions
- Resolution Ap (2000) 1
- Silibinin and SARS-Cov-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients
- (12) United States Patent (10) Patent No.: US 9,616,033 B2 Gerk Et Al
- New Phytochemicals As Potential Human Anti-Aging Compounds: Reality, Promise, and Challenges
- Silibinin Suppresses TNF-A-Induced MMP-9 Expression in Gastric Cancer Cells Through Inhibition of the MAPK Pathway
- Secoisolariciresinol Diglucoside (SDG) Scavenges ACS - a Novel Mechanism of DNA Radioprotection